The Patent Finder

Nuchem Pharmaceuticals Inc.

Also on record
Records under this name other than patents Nuchem Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Nuchem Pharmaceuticals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,028,103Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
Term ended
Term ended Mar 19, 2017 · USPTO record
Term endedTerm ended Mar 19, 2017USPTO record
US 6,992,079Substituted 11-Phenyl-DIBENZAZEPINE Compounds Useful for the Treatment or Prevention of Diseases Characterized by Abnormal Cell Proliferation
Lapsed on the fee record
Ended Jan 31, 2014 · Low confidence
Lapsed on the fee recordEnded Jan 31, 2014Low confidence
US 6,800,658Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
Lapsed on the fee record
Ended Oct 5, 2012 · USPTO record
Lapsed on the fee recordEnded Oct 5, 2012USPTO record
US 7,342,038Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
Lapsed on the fee record
Ended Mar 11, 2012 · USPTO record
Lapsed on the fee recordEnded Mar 11, 2012USPTO record
US 6,534,497Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
Lapsed on the fee record
Ended Mar 18, 2011 · USPTO record
Lapsed on the fee recordEnded Mar 18, 2011USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited